Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2022 Filed Jul 18, 2022 10:02 UTC |
Sindlev ReneDirector · 10% owner
|
OtherCommon Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001731122-22-001223 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Arving ApS Disclosed balance after: 0 F1 · kind: On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid. F1 · price: On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid. Read SEC document |
| May 26, 2022 Filed Jun 13, 2022 16:56 UTC |
McNicol JayneDirector
|
GrantOption to purchase shares of common stock · Derivative | 16,892 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001731122-22-001059 · ownership.xml · derivative · entry 1 McNicol Jayne · CIK 0001866827 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,892 Underlying: Common stock · 16,892 shares Expires 2032-05-26 Read SEC document |
| May 18, 2022 Filed May 20, 2022 21:37 UTC |
Gumrukcu Serhat10% owner
|
SaleCommon Stock | 128,493 | $8.00 | $1,027,944.00 |
DisclosureSEC source: 0001731122-22-000960 · ownership.xml · nonDerivative · entry 2 Gumrukcu Serhat · CIK 0001813678 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,273,059 Read SEC document |
| May 18, 2022 Filed May 20, 2022 21:37 UTC |
Gumrukcu Serhat10% owner
|
SaleCommon Stock | 125,000 | $8.00 | $1,000,000.00 |
DisclosureSEC source: 0001731122-22-000960 · ownership.xml · nonDerivative · entry 1 Gumrukcu Serhat · CIK 0001813678 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,401,552 Read SEC document |
| May 18, 2022 Filed May 21, 2022 01:32 UTC |
Sindlev ReneDirector · 10% owner
|
PurchaseCommon Stock | 128,493 | $8.00 | $1,027,944.00 |
DisclosureSEC source: 0001731122-22-000958 · ownership.xml · nonDerivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 128,493 Read SEC document |
| May 18, 2022 Filed May 21, 2022 01:32 UTC |
Sindlev ReneDirector · 10% owner
|
PurchaseCommon Stock | 125,000 | $8.00 | $1,000,000.00 |
DisclosureSEC source: 0001731122-22-000958 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Arving ApS Disclosed balance after: 125,000 Read SEC document |
| April 15, 2022 Filed Aug 3, 2022 09:16 UTC |
Sandler Carl ForestFormer director see note below
|
OtherCommon Stock | 992,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001085146-22-002743 · ownership.xml · nonDerivative · entry 2 Sandler Carl Forest · CIK 0001734560 · Former director see note below 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,449,104 Read SEC document |
| April 15, 2022 Filed Aug 3, 2022 09:16 UTC |
Sandler Carl ForestFormer director see note below
|
OtherCommon Stock | 3,969,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001085146-22-002743 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest · CIK 0001734560 · Former director see note below 10b5-1 filing: Not disclosed Ownership: Indirect · N/A Disclosed balance after: 3,456,831 F1 · ownership.direct: By Weird Science, LLC Read SEC document |
| April 15, 2022 Filed Feb 7, 2023 00:24 UTC |
Weird Science LLC10% owner
|
OtherCommon Stock | 4,961,363 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-23-001671 · marketforms-58228.xml · nonDerivative · entry 7 Weird Science LLC · CIK 0001955760 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,032 F3 · kind: Pro rata distribution to the members of the Reporting Person. F3 · price: Pro rata distribution to the members of the Reporting Person. Read SEC document |
| April 11, 2022 Filed Feb 6, 2023 19:29 UTC |
William Anderson Wittekind10% owner
|
OtherCommon Stock | 97,032 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-23-001675 · marketforms-58230.xml · nonDerivative · entry 1 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Weird Science LLC Disclosed balance after: 5,058,395 F1 · kind: Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement. F1 · price: Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement. F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC. Read SEC document |
| April 11, 2022 Filed Feb 7, 2023 00:24 UTC |
Weird Science LLC10% owner
|
OtherCommon Stock | 97,032 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-23-001671 · marketforms-58228.xml · nonDerivative · entry 6 Weird Science LLC · CIK 0001955760 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,058,395 F2 · kind: Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement. F2 · price: Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 16:30 UTC |
Sandler Carl ForestDirector · 10% owner
|
SaleCommon Stock | 1,927 | $9.06 | $17,458.62 |
DisclosureSEC source: 0001731122-22-000522 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,187,487 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021. Read SEC document |
| February 23, 2022 Filed Feb 23, 2022 17:18 UTC |
Sandler Carl ForestDirector · 10% owner
|
SaleCommon Stock | 6 | $9.00 | $54.00 |
DisclosureSEC source: 0001731122-22-000303 · ownership.xml · nonDerivative · entry 2 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189,414 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 17:18 UTC |
Sandler Carl ForestDirector · 10% owner
|
SaleCommon Stock | 6,792 | $9.03 | $61,348.06 |
DisclosureSEC source: 0001731122-22-000303 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189,420 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021. Read SEC document |
| January 12, 2022 Filed Feb 6, 2023 19:30 UTC |
William Anderson Wittekind10% owner
|
GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001676 · marketforms-58235.xml · nonDerivative · entry 3 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,623,484 Read SEC document |
| December 28, 2021 Filed Jan 7, 2022 18:32 UTC |
Sandler Carl ForestDirector · 10% owner
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-22-000033 · ownership.xml · nonDerivative · entry 3 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,196,212 Read SEC document |
| December 28, 2021 Filed Jan 7, 2022 18:32 UTC |
Sandler Carl ForestDirector · 10% owner
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-22-000033 · ownership.xml · nonDerivative · entry 2 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,197,712 Read SEC document |
| December 28, 2021 Filed Jan 7, 2022 18:32 UTC |
Sandler Carl ForestDirector · 10% owner
|
GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-22-000033 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,199,212 Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 02:41 UTC |
Alton Gregg HDirector
|
GrantOption to purchase shares of common stock · Derivative | 9,458 | $0.00 Strike: $7.93 | $0.00 |
DisclosureSEC source: 0001731122-21-002209 · ownership.xml · derivative · entry 1 Alton Gregg H · CIK 0001334682 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,458 Underlying: Common stock · 9,458 shares Expires 2031-12-27 Read SEC document |
| December 27, 2021 Filed Jan 3, 2022 11:01 UTC |
Brosgart Carol LDirector
|
GrantOption to purchase shares of common stock · Derivative | 9,458 | $0.00 Strike: $7.93 | $0.00 |
DisclosureSEC source: 0001731122-22-000002 · ownership.xml · derivative · entry 1 Brosgart Carol L · CIK 0001614724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,458 Underlying: Common stock · 9,458 shares Expires 2031-12-27 Read SEC document |
| December 22, 2021 Filed Jan 4, 2022 23:11 UTC |
Gronfeldt-Sorensen HenrikDirector
|
GrantOption to purchase shares of common stock · Derivative | 3,646 | $0.00 Strike: $8.23 | $0.00 |
DisclosureSEC source: 0001731122-22-000015 · ownership.xml · derivative · entry 1 Gronfeldt-Sorensen Henrik · CIK 0001720024 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,646 Underlying: Common stock · 3,646 shares Expires 2031-10-09 Read SEC document |
| December 22, 2021 Filed Jan 4, 2022 22:14 UTC |
Sindlev ReneDirector · 10% owner
|
GrantOption to purchase shares of common stock · Derivative | 3,646 | $0.00 Strike: $8.23 | $0.00 |
DisclosureSEC source: 0001731122-22-000010 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,646 Underlying: Common Stock · 3,646 shares Expires 2031-12-22 Read SEC document |
| December 16, 2021 Filed Dec 21, 2021 00:01 UTC |
Puche LuisaChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 16,266 | $7.75 Strike: $7.75 | $126,061.50 |
DisclosureSEC source: 0001731122-21-002163 · ownership.xml · derivative · entry 1 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,266 Underlying: Common Stock · 16,266 shares Expires 2031-12-16 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of Enochian Biosciences Inc. common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under the Enochian BioSciences Inc. 2019 Equity Incentive Plan. 11,266 of the restricted stock units shall vest on the Grant Date; the remaining 5,000 restricted stock units shall vest on January 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 16, 2021 Filed Jan 11, 2022 22:54 UTC Amendment |
Puche LuisaChief Financial Officer
|
GrantCommon Stock | 16,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-22-000044 · ownership.xml · nonDerivative · entry 2 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,266 F2 · shares: Ms. Puche received restricted stock units under the Issuer's 2019 Equity Incentive Plan. 11,266 of the restricted stock units vested on the Grant Date; the remaining 5,000 restricted stock units vested on January 7, 2022. Upon vesting, the reporting person received a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 16, 2021 Filed Jan 11, 2022 22:54 UTC Amendment |
Puche LuisaChief Financial Officer
|
Disposition to issuerCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-22-000044 · ownership.xml · nonDerivative · entry 1 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The Issuer cancelled the shares of common stock previously issued to Ms. Puche upon the vesting of certain restricted stock units. Read SEC document |
| December 14, 2021 Filed Feb 6, 2023 19:30 UTC |
William Anderson Wittekind10% owner
|
GiftCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001676 · marketforms-58235.xml · nonDerivative · entry 2 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,627,484 Read SEC document |
| October 26, 2021 Filed Nov 23, 2021 17:41 UTC |
Puche LuisaChief Financial Officer
|
GrantOption to purchase shares of common stock · Derivative | 60,000 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001731122-21-002049 · ownership.xml · derivative · entry 1 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common stock · 60,000 shares Expires 2031-10-26 F1 · derivative.exercise_date: The options vest ratably on October 26, 2022, October 26, 2023 and October 26, 2024. Read SEC document |
| October 20, 2021 Filed Feb 6, 2023 19:30 UTC |
William Anderson Wittekind10% owner
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001676 · marketforms-58235.xml · nonDerivative · entry 1 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,629,884 Read SEC document |
| October 11, 2021 Filed Dec 22, 2021 16:07 UTC |
Gronfeldt-Sorensen HenrikDirector
|
GrantOption to purchase shares of common stock · Derivative | 10,519 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001731122-21-002174 · ownership.xml · derivative · entry 1 Gronfeldt-Sorensen Henrik · CIK 0001720024 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Greenfield Holding ApS Disclosed balance after: 10,519 Underlying: Common stock · 10,519 shares Expires 2031-10-11 F1 · shares: On October 11, 2021, Mr. Gronfeldt-Sorensen was granted an option to purchase 10,519 shares of common stock of Enochian Biosciences Inc., said option to vest on October 11, 2022. Read SEC document |
| October 11, 2021 Filed Jan 4, 2022 23:08 UTC Amendment |
Gronfeldt-Sorensen HenrikDirector
|
GrantOption to purchase shares of common stock · Derivative | 10,519 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001731122-22-000013 · ownership.xml · derivative · entry 1 Gronfeldt-Sorensen Henrik · CIK 0001720024 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,519 Underlying: Common stock · 10,519 shares Expires 2031-10-11 F1 · ownership.direct: The reporting person is amending the Form 4 originally filed to report that the form of ownership is direct and not indirect. Read SEC document |
| July 28, 2021 Filed Dec 22, 2021 16:30 UTC |
Sindlev ReneDirector · 10% owner
|
GrantOption to purchase shares of common stock · Derivative | 9,036 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001731122-21-002180 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,036 Underlying: Common Stock · 9,036 shares Expires 2031-07-28 F1 · shares: On July 28, 2021, Mr. Sindlev was granted an option to purchase 9,036 shares of the issuer's common stock, fully vesting on July 28, 2022. Read SEC document |
| July 19, 2021 Filed Jul 22, 2021 20:33 UTC |
Dybul MarkDirector · Chief Executive Officer
|
GrantOption to purchase shares of common stock · Derivative | 2,000,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0001731122-21-001219 · ownership.xml · derivative · entry 1 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common stock · 2,000,000 shares Expires 2031-07-19 F1 · derivative.exercise_date: The options vest ratably on July 1, 2022, July 1, 2023 and July 1, 2024. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 15:49 UTC |
McNicol JayneDirector
|
GrantOption to purchase shares of common stock · Derivative | 26,498 | $0.00 Strike: $5.78 | $0.00 |
DisclosureSEC source: 0001731122-21-001096 · ownership.xml · derivative · entry 1 McNicol Jayne · CIK 0001866827 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,498 Underlying: Common stock · 26,498 shares Expires 2031-06-24 Read SEC document |
| April 22, 2021 Filed Feb 6, 2023 19:27 UTC |
William Anderson Wittekind10% owner
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001674 · marketforms-58234.xml · nonDerivative · entry 5 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,632,884 Read SEC document |
| April 08, 2021 Filed Feb 6, 2023 19:27 UTC |
William Anderson Wittekind10% owner
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001674 · marketforms-58234.xml · nonDerivative · entry 4 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,635,884 Read SEC document |
| March 11, 2021 Filed Feb 6, 2023 19:27 UTC |
William Anderson Wittekind10% owner
|
GiftCommon Stock | 74,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001674 · marketforms-58234.xml · nonDerivative · entry 3 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,638,884 Read SEC document |
| March 06, 2021 Filed Mar 12, 2021 01:03 UTC |
D An EvelynDirector
|
GrantOption to Purchase Common Stock · Derivative | 19,894 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001731122-21-000359 · ownership.xml · derivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,894 Underlying: Common Stock · 19,894 shares Expires 2031-03-06 F1 · security: On March 6, 2021, Ms. D'An was granted an option to purchase 19,894 shares of common stock of Enochian Biosciences Inc., said option to vest on March 6, 2022. Read SEC document |
| March 06, 2021 Filed Mar 12, 2021 01:02 UTC |
SAPIRSTEIN JAMESDirector
|
GrantOption to Purchase Common Stock · Derivative | 19,894 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001731122-21-000358 · ownership.xml · derivative · entry 1 SAPIRSTEIN JAMES · CIK 0001559509 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,894 Underlying: Common Stock · 19,894 shares Expires 2031-03-06 F1 · security: On March 6, 2021, Mr. Sapirstein was granted an option to purchase 19,894 shares of common stock of Enochian Biosciences Inc., said option to vest on March 6, 2022. Read SEC document |
| February 28, 2021 Filed Dec 22, 2021 11:18 UTC |
Sandler Carl ForestDirector · 10% owner
|
GrantOption to purchase shares of common stock · Derivative | 12,712 | $0.00 Strike: $3.54 | $0.00 |
DisclosureSEC source: 0001731122-21-002178 · ownership.xml · derivative · entry 1 Sandler Carl Forest Jr · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,712 Underlying: Common stock · 12,712 shares Expires 2031-02-28 F1 · shares: On February 28, 2021, Mr. Sandler was granted an option to purchase 12,712 shares of common stock of Enochian Biosciences Inc., said option to vest on February 28, 2022. Read SEC document |
| December 28, 2020 Filed Dec 21, 2021 16:50 UTC |
Brosgart Carol LDirector
|
GrantOption to purchase shares of common stock · Derivative | 25,424 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001731122-21-002169 · ownership.xml · derivative · entry 1 Brosgart Carol L · CIK 0001614724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,424 Underlying: Common stock · 25,424 shares Expires 2030-12-28 F1 · shares: On December 28, 2020, Dr. Brosgart was granted an option to purchase 25,424 shares of common stock of Enochian Biosciences Inc., said option to vest on December 28, 2021. Read SEC document |
| December 28, 2020 Filed Dec 22, 2021 16:10 UTC |
Alton Gregg HDirector
|
GrantOption to purchase shares of common stock · Derivative | 25,424 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001731122-21-002176 · ownership.xml · derivative · entry 1 Alton Gregg H · CIK 0001334682 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,424 Underlying: Common stock · 25.424 shares Expires 2030-12-28 F1 · shares: On December 3, 2020, Mr. Alton was granted an option to purchase 25,424 shares of common stock of Enochian Biosciences Inc., said option to vest on December 28, 2021. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 14:00 UTC |
Sandler Carl ForestDirector · 10% owner
William Anderson Wittekind10% owner
|
OtherCommon Stock | 61,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-20-001303 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest Jr · CIK 0001734560 · Director · 10% owner William Anderson Wittekind · CIK 0001753085 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Weird Science, LLC Disclosed balance after: 4,961,363 F1 · security: On December 14, 2020, Weird Science, LLC received 61,249 shares of common stock pursuant to a contractual right to receive shares upon the exercise of outstanding warrants of the Issuer. Mr. Sandler and W. Anderson Wittekind are each managers of Weird Science and share investment control over the shares held by Weird Science, LLC. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 19:03 UTC |
Dybul MarkDirector · Executive Vice Chair
|
OtherCommon Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-20-001305 · ownership.xml · nonDerivative · entry 1 Dybul Mark · CIK 0001734805 · Director · Executive Vice Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,196 F1 · security: On December 14, 2020, Mark Dybul received 180 shares of common stock pursuant to a contractual right to receive shares upon the exercise of outstanding warrants of the Issuer. Read SEC document |
| December 14, 2020 Filed Feb 6, 2023 19:27 UTC |
William Anderson Wittekind10% owner
|
GiftCommon Stock | 904,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001674 · marketforms-58234.xml · nonDerivative · entry 2 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,763,384 Read SEC document |
| December 14, 2020 Filed Feb 7, 2023 00:24 UTC |
Weird Science LLC10% owner
|
OtherCommon Stock | 61,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-23-001671 · marketforms-58228.xml · nonDerivative · entry 5 Weird Science LLC · CIK 0001955760 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,961,363 F2 · kind: Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement. F2 · price: Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement. Read SEC document |
| August 25, 2020 Filed Feb 6, 2023 19:27 UTC |
William Anderson Wittekind10% owner
|
GiftCommon Stock | 111,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001674 · marketforms-58234.xml · nonDerivative · entry 1 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,398,056 Read SEC document |
| June 11, 2020 Filed Jun 19, 2020 19:01 UTC |
Dybul MarkDirector · Executive Vice Chair
|
GrantOption to Purchase Common Stock · Derivative | 450,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001731122-20-000662 · ownership.xml · derivative · entry 1 Dybul Mark · CIK 0001734805 · Director · Executive Vice Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2030-06-11 Read SEC document |
| May 29, 2020 Filed Feb 7, 2023 00:24 UTC |
Weird Science LLC10% owner
|
OtherCommon Stock | 17,545,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-23-001671 · marketforms-58228.xml · nonDerivative · entry 4 Weird Science LLC · CIK 0001955760 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900,114 F3 · kind: Pro rata distribution to the members of the Reporting Person. F3 · price: Pro rata distribution to the members of the Reporting Person. Read SEC document |
| April 06, 2020 Filed Dec 21, 2021 16:50 UTC |
Brosgart Carol LDirector
|
GrantOption to purchase shares of common stock · Derivative | 15,625 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001731122-21-002169 · ownership.xml · derivative · entry 2 Brosgart Carol L · CIK 0001614724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Common stock · 15,625 shares Expires 2030-04-06 F2 · shares: On April 6, 2020, Dr. Brosgart was granted an option to purchase 15,625 shares of common stock of Enochian Biosciences Inc., said option to vest on December 27, 2020. Read SEC document |
| April 06, 2020 Filed Dec 22, 2021 16:10 UTC |
Alton Gregg HDirector
|
GrantOption to purchase shares of common stock · Derivative | 15,625 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001731122-21-002176 · ownership.xml · derivative · entry 2 Alton Gregg H · CIK 0001334682 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Common stock · 15,625 shares Expires 2030-04-06 F2 · shares: On April 6, 2020, Mr. Alton was granted an option to purchase 15,625 shares of common stock of Enochian Biosciences Inc., said option to vest on December 27, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.